Innovation Spotlight: The Future of Business
4 months ago
Immatics' $125M Raise: Fueling a New Wave of Cancer Therapies
Immatics just secured $125M. This cash infusion is a major bet on its pioneering PRAME-targeted therapies and a key signal for the future of oncology.
Read full article
